Liz Yamashita

Liz Yamashita has over 35 years of experience in the pharmaceutical industry, spanning small molecule and biotechnology CMC, clinical and nonclinical development, as well as marketing, and business development. During her career, Liz has managed all aspects of regulatory affairs, strategy and operational work from initial health authority interactions through marketing application approvals. Liz has held executive positions at Oncobiologics Inc., Savient Pharmaceuticals, Inc. and ImClone Systems (now Eli Lilly). Liz holds a B.S. degree in Chemistry from the University of Rochester.